Pharmalink strengthens team in preparation for Phase III trials with Nefecon in IgA Nephropathy, a progressive inflammatory kidney disease December 12, 2016 15:34 CET Non Regulatory Read more
Pharmalink announces European orphan drug designation for Nefecon® for treatment of IgA Nephropathy, an inflammatory kidney disease November 29, 2016 15:31 CET Non Regulatory Read more
